Articles related to CONTROLLED MEDICINES

AI-driven opioid monitoring systems are increasingly influencing medical decisions, but questions about their accuracy and potential bias persist. Learn how these tools could impact your practice and patient care.

The DEA’s upcoming guidelines could reshape how controlled substances are prescribed via telehealth. Stay informed and consider participating in the DEA’s listening sessions to ensure your practice adapts smoothly.

Discover how researchers have overcome a significant chemical hurdle in methylphenidate, potentially paving the way for more effective treatments for cocaine addiction.

Discover the advancements in MDD pharmacotherapy that promise to expand treatment options and address unmet needs.

Explore the DEA’s latest regulations on electronic prescriptions for controlled substances, a significant step towards modernizing pharmacy practices. Learn more about how these changes may impact the way prescriptions are transferred and managed, aligning with current technological advancements and legal requirements.

The DEA and FDA are addressing the current prescription stimulant shortage, emphasizing both the importance of patient access and the need for responsible prescribing. Stay informed on the latest updates and consider alternative treatments where appropriate.